Global Magnetic Resonance Imaging Market Outlook, Trends And Future Opportunities (2024-2035)

Global Magnetic Resonance Imaging Market Outlook, Trends And Future Opportunities (2024-2035)

Global Magnetic Resonance Imaging Market, By Product Type (Closed MRI Systems, Open MRI Systems), By Field Strength (Low Field MRI Systems, Mid Field MRI Systems, High Field MRI Systems, Ultra High Field MRI Systems), By Application (Brain & Neurological, Spine & Musculoskeletal, Vascular, Cardiac, Breast, Abdominal, Pelvic), By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research Institutes), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Jul 2025
  • Author(s): Sagar Karlekar
  • Report ID: IDA180
  • Region: Global
  • Format: PDF/EXCEL

Market Segmentation:

  • By Field Strength
    • Low-field MRI (0.2T - 0.5T)
    • Mid-field MRI (0.5T - 1T)
    • High-field MRI (1.5T - 3T)
    • Ultra-high-field MRI (3T - 7T)
    • Research MRI (>7T)
  • By Architecture
    • Closed MRI Systems
    • Open MRI Systems
    • Wide-bore MRI Systems
    • Extremity MRI Systems
    • Portable MRI Systems
    • Interventional MRI Systems
    • Others (Upright MRI, Dedicated Breast MRI)
    • Regions
  • By Application
    • Brain and Neurological Imaging
    • Spine and Musculoskeletal
    • Cardiovascular Imaging
    • Abdominal and Pelvic Imaging
    • Breast Imaging
    • Oncology Applications
    • Others (Pediatric, Interventional, Research)
  • By End User
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Surgical Centers
    • Research Institutes
    • Others (Specialty Clinics, Academic Centers)
  • By Technology
    • Superconducting MRI
    • Permanent Magnet MRI
    • Resistive Magnet MRI
    • Hybrid MRI Systems
    • Others (Functional MRI, Diffusion MRI)
  • By Contrast Agent
    • Gadolinium-based Contrast Agents
    • Superparamagnetic Iron Oxide
    • Manganese-based Contrast Agents
    • Others (Experimental Agents, Natural Contrast)
  • By Acquisition Type
    • New MRI System Sales
    • Refurbished MRI Systems
    • MRI Upgrade Services
    • MRI Leasing Services
    • Others (Service Contracts, Parts)
  • By Regions
    • North America
      • United States
      • Canada
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East

Frequently Asked Questions

The global Magnetic resonance imaging market is valued at USD 9.3 billion in 2024 and is projected to reach USD 18.1 billion by 2035.

Rising chronic disease prevalence, aging population, advanced healthcare infrastructure, technological innovations, AI integration, portable systems development, increased healthcare expenditure, early diagnosis awareness, non-invasive procedure preference, and emerging market expansion.

High equipment costs, complex maintenance requirements, skilled technician shortage, stringent regulatory approvals, lengthy installation processes, operational complexity, and limited reimbursement policies.

The leading component segment in the Magnetic Resonance Imaging Market is high-field MRI systems for comprehensive clinical diagnostic applications.

Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Esaote S.p.A, Fonar Corporation, Shanghai United Imaging Healthcare, Hitachi Medical Corporation, Neusoft Medical Systems, and other established manufacturers.

The North America region is expected to lead the Magnetic Resonance Imaging Market with 34% market share and 6.2% CAGR.

Rising chronic disease prevalence, aging population growth, advanced healthcare infrastructure development, technological innovations, AI integration, non-invasive diagnostic preference, and emerging market expansion opportunities.